棕榈酸帕利哌酮注射液在精神分裂症患者治疗中的综合评价

The review of palmitate paliperdone injection in the treatment of schziophrenia

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2023, 50(6)
作者
作者单位

昆明医科大学第一附属医院 ;

摘要
精神分裂症于青壮年发病,大部分患者服药依从性差,导致症状反复,病程迁延,社会功能持续减退。长效针剂棕榈酸帕利哌酮能提高患者长期治疗的依从性,减少复发及再入院率,并改善其社会功能,其临床疗效、成本效益优于绝大部分口服抗精神病药物。在医院-社区一体化管理模式下,棕榈酸帕利哌酮的优势进一步显现。本综述旨在讨论棕榈酸帕利哌酮长效针剂治疗精神分裂症的复发率、安全性、成本效益以及探讨其在医院-社区一体化管理模式下应用的重要性。
Abstract
Schizophrenia occurs in young adults. Most patients have poor drug compliance, leading to repeated symptoms, prolonged course of disease, and continuous decline of social function. The long-term injection of paliperidone palmitate can improve the compliance of patients with long-term treatment, reduce recurrence and readmission rates, and improve their social functions. Its clinical efficacy and cost-effectiveness are superior to most oral antipsychotics. Under the hospital community integrated management mode, the advantages of palmitate paliperidone are further revealed. The purpose of this review is to discuss the recurrence rate, safety, cost-effectiveness of palmitate long-acting injection in the treatment of schizophrenia and the importance of its application in the hospital community integrated management model.
关键词
精神分裂症;棕榈酸帕利哌酮;复发率;成本效益;医院-社区一体化
KeyWord
Schizophrenia; Palmitate paliperidone; Recurrence rates; Cost-effectiveness; The hospital community integrated management model
基金项目
页码 1285-1288
  • 参考文献
  • 相关文献
  • 引用本文

罗星,王级才*. 棕榈酸帕利哌酮注射液在精神分裂症患者治疗中的综合评价 [J]. 国际精神病学杂志. 2023; 50; (6). 1285 - 1288.

  • 文献评论

相关学者

相关机构